iBio Analyst Price Targets

Wall Street analyst price targets and consensus rating for iBio (IBIO).

Price Target Range — 8 Quarters

Analyst Consensus — 8 Analysts

8Buy

Consensus RatingBuy# Analysts8Avg. Consensus PT$5Upside to Avg. PT+490.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 17, 2026	HC Wainwright & Co.	Ananda Ghosh	Initiate	Buy	$7
Jul 2, 2026	Chardan Capital	Keay Nakae	Maintained	Buy	$5
Jun 8, 2026	Raymond James	Martin Auster	Initiate	Outperform	$5
Apr 9, 2026	Chardan Capital	Keay Nakae	Maintained	Buy	$5
Mar 18, 2026	Chardan Capital	Keay Nakae	Maintained	Buy	$5
Mar 3, 2026	Jones Trading	Catherine Novack	Initiate	Buy	$7
Feb 12, 2026	Chardan Capital	Keay Nakae	Maintained	Buy	$5
Oct 21, 2025	Oppenheimer	Jay Olson	Initiate	Outperform	$5
Oct 17, 2025	Leerink Partners	Roanna Ruiz	Initiate	Outperform	$2
Jun 25, 2025	Chardan Capital	Keay Nakae	Maintained	Buy	$5
May 6, 2025	Chardan Capital	Keay Nakae	Maintained	Buy	$5
May 5, 2025	Chardan Capital	Keay Nakae	Maintained	Buy	$5
Dec 17, 2024	LUCID CAPITAL MARKETS	Dev Prasad	Initiate	Buy	$6
Jul 22, 2024	Brookline Capital	Kemp Dolliver	Initiate	Buy	$4
Jun 3, 2024	Chardan Capital	Keay Nakae	Maintained	Buy	$5
May 28, 2024	Chardan Capital	Keay Nakae	Initiate	Buy	$5

More with Benzinga EdgeGet Access

Analyst Ratings News

This Paymentus Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Analysts initiated coverage: Buy ratings for MNOV ($6), IBIO ($7), ROIV ($51), and PAY ($42); FHN rated Market Perform at $25.

Avi Kapoor

PRO
HC Wainwright & Co. Initiates Coverage On iBio with Buy Rating, Announces Price Target of $7

HC Wainwright & Co. analyst Ananda Ghosh initiates coverage on iBio (NASDAQ:IBIO) with a Buy rating and announces Price Target of $7.

Benzinga Newsdesk

PRO
Raymond James Initiates Coverage On iBio with Outperform Rating, Announces Price Target of $5

Raymond James analyst Martin Auster initiates coverage on iBio (NASDAQ:IBIO) with a Outperform rating and announces Price Target of $5.

Benzinga Newsdesk

PRO
Jones Trading Initiates Coverage On iBio with Buy Rating, Announces Price Target of $7

Jones Trading analyst Catherine Novack initiates coverage on iBio (NASDAQ:IBIO) with a Buy rating and announces Price Target of $7.

Benzinga Newsdesk

PRO
Chardan Capital Maintains Buy on iBio, Maintains $5 Price Target

Chardan Capital analyst Keay Nakae maintains iBio (NASDAQ:IBIO) with a Buy and maintains $5 price target.

Benzinga Newsdesk

This ACADIA Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Avi Kapoor

iBio Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

iBio Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

This Paymentus Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

PRO
HC Wainwright & Co. Initiates Coverage On iBio with Buy Rating, Announces Price Target of $7

PRO
Raymond James Initiates Coverage On iBio with Outperform Rating, Announces Price Target of $5

PRO
Jones Trading Initiates Coverage On iBio with Buy Rating, Announces Price Target of $7

PRO
Chardan Capital Maintains Buy on iBio, Maintains $5 Price Target

This ACADIA Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

People Also Watch

People Also Watch

iBio Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

iBio Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

This Paymentus Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

PROHC Wainwright & Co. Initiates Coverage On iBio with Buy Rating, Announces Price Target of $7

PRORaymond James Initiates Coverage On iBio with Outperform Rating, Announces Price Target of $5

PROJones Trading Initiates Coverage On iBio with Buy Rating, Announces Price Target of $7

PROChardan Capital Maintains Buy on iBio, Maintains $5 Price Target

This ACADIA Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Initiates Coverage On iBio with Buy Rating, Announces Price Target of $7

PRO
Raymond James Initiates Coverage On iBio with Outperform Rating, Announces Price Target of $5

PRO
Jones Trading Initiates Coverage On iBio with Buy Rating, Announces Price Target of $7

PRO
Chardan Capital Maintains Buy on iBio, Maintains $5 Price Target